相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Molecular imaging of β-cells: diabetes and beyond
Weijun Wei et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Exendin-4 analogs in insulinoma theranostics
Tom J. P. Jansen et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2019)
被撤回的出版物: Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT (Retracted article. See vol. 161, 2020)
Takaaki Murakami et al.
ENDOCRINOLOGY (2019)
Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe
Keita Hamamatsu et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
Pancreatic imaging using an antibody fragment targeting the zinc transporter type 8: a direct comparison with radio-iodinated Exendin-4
Olof Eriksson et al.
ACTA DIABETOLOGICA (2018)
Targets and probes for non-invasive imaging of β-cells
Andreas Jodal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake
Tilman Laeppchen et al.
PLOS ONE (2017)
Synthesis and biological evaluation of an 111In-labeled exendin-4 derivative as a single-photon emission computed tomography probe for imaging pancreatic β-cells
Hiroyuki Kimura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Role and development of GLP-1 receptor agonists in the management of diabetes
Josephine Egan et al.
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (2016)
Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin
Maarten Brom et al.
DIABETOLOGIA (2014)
Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans
J. J. Meier et al.
DIABETOLOGIA (2012)
Micro-CT Based Experimental Liver Imaging Using a Nanoparticulate Contrast Agent: A Longitudinal Study in Mice
Hanne Boll et al.
PLOS ONE (2011)
Understanding GLP-1 Analogs and Enhancing Patient Success
Davida F. Kruger et al.
DIABETES EDUCATOR (2010)
GLP-1 receptor antagonist as a potential probe for pancreatic β-cell imaging
Eri Mukai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Pancreatic β-cell mass in European subjects with type 2 diabetes
J. Rahier et al.
DIABETES OBESITY & METABOLISM (2008)
Beta cell mass in diabetes: a realistic therapeutic target?
J. J. Meier
DIABETOLOGIA (2008)
Islet cell function: alpha and beta cells - partners towards normoglycaemia
B. Goeke
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain
Steffen Runge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of the GLP-1 Receptor in Mouse, Rat, and Human Pancreas
Ditte Tornehave et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats
Torsten P. Vahl et al.
ENDOCRINOLOGY (2007)
Effect of renal impairment on the pharmacokinetics of exenatide
Helle Linnebjerg et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain
Steffen Runge et al.
BIOCHEMISTRY (2007)
Investigation of exenatide elimination and its in vivo and in vitro degradation
Kathrin Copley et al.
CURRENT DRUG METABOLISM (2006)
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs
L Simonsen et al.
DIABETOLOGIA (2006)
Identification of tissue-restricted transcripts in human islets
A Maffei et al.
ENDOCRINOLOGY (2004)
Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells
M Hara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
A novel route to radioiodinated [123I]-N-succinimidyl-3-iodobenzoate, a reagent for radioiodination of bioactive peptides
I Al-Jammaz et al.
APPLIED RADIATION AND ISOTOPES (2002)
Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients
H Sakuraba et al.
DIABETOLOGIA (2002)